THERANICA USA, INC.

THERANICA USA, INC. specializes in the design, development, and manufacturing of advanced medical devices, with a focus on neurostimulation technologies and precision therapeutic systems. Operating under NAICS 334510, the company leverages expertise in biomedical engineering, embedded systems, and low-power electronics to create FDA-regulated devices intended for clinical use. Their technical capabilities include wearable neuromodulation platforms, closed-loop sensing architectures, and regulatory-compliant software validation processes aligned with ISO 13485 and IEC 60601 standards. Differentiators include miniaturized hardware design, patient-centric interface development, and rigorous adherence to quality management systems for Class II medical devices. Award history is not available to confirm specific agency engagements, and no recent contract data is provided to infer federal partnerships. Consequently, there is no verifiable evidence of direct work with government health, defense, or research agencies. The company’s primary industry focus is the medical device manufacturing sector, where it develops Class II therapeutic devices for neurological and pain management applications. This positions THERANICA USA, INC. within the broader healthcare technology market, serving clinical and commercial channels through innovation in non-pharmacological interventions. As a small business structured as a 2L entity, THERANICA USA, INC. is headquartered in Bridgewater, New Jersey, with operations centered on R&D and high-precision manufacturing. The company holds no federal certifications, including 8(a), HUBZone, or WOSB status, and its market presence is primarily commercial, with no confirmed government contracting footprint based on available data.